Search Results
Nov 19, 2025, 08:15 ET AIUM Expands Guidelines to Include Chlorine Dioxide for High-Level Disinfection of Ultrasound Probes
comparative analysis presented by Nancy Moureau, RN, PhD, CRNI, CPUI, VA-BC, CEO of PICC Excellence, and Connie Cutler, showed chlorine dioxide foam used
More news about: Parker Laboratories
Nov 19, 2025, 08:06 ET Dalan Animal Health Closes $3M Seed Round via SAFE Financing to Advance Commercialization of First-in-Class Shrimp Vaccine and Expand Platform Applications
largest seafood protein, is not only a huge market, but is proving Dalan's platform technology is applicable to many species," said Maureen Stancik Boyce, PhD, Founder and Managing Partner of Good Growth Capital. European Operations Strengthened with Research Grant
More news about: Dalan Animal Health, Inc.
Nov 19, 2025, 07:30 ET Autoimmunity BioSolutions Bolsters Leadership Team
acquisition of Momenta Pharmaceuticals. ABS has also expanded its operating advisors to include Alidad Mireskandari, PhD, as the Scientific Advisor of Diagnostics and Robert McBurney, PhD, as the Director of Personalized Medicine Strategy. "I am very grateful that each of these highly
More news about: Autoimmunity BioSolutions
Nov 19, 2025, 07:30 ET Soligenix Achieves Enrollment Milestone for Planned Interim Analysis in Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma
have reached this important milestone in patient enrollment consistent with our timelines for the FLASH2 study," stated Christopher J. Schaber, PhD, President and Chief Executive Officer of Soligenix. "With 50 patients enrolled, the planned interim analysis will occur in the second quarter of 2026.
More news about: SOLIGENIX, INC.
Nov 18, 2025, 16:15 ET Kazia Therapeutics Achieves Initial iCR (Immune-Complete Response) in Metastatic TNBC and Delivers Q4 Business Update with Breakthroughs Across Breast Cancer, Immuno-Oncology, and GBM Regulatory Strategy
overcome metastasis and immunotherapy resistance in TNBC" – Sudha Rao, PhD, QIMR Berghofer (Australia) Epigenetic checkpoint blockade: A new booster to enhance immunogenicity" Sherry Tu, PhD, QIMR Berghofer (Australia) Kazia
More news about: Kazia Therapeutics Limited
Nov 18, 2025, 15:20 ET The Inner Circle acknowledges, Jennifer Garrison as an Inner Circle Lifetime Member
intelligence and machine learning, and the development of the Federal Health platform on an international scale. Dr. Garrison holds a PhD in Health Sciences from Walden University, earned in 2015, and is set to receive a DBA from Walden University in the summer of 2026. She is affiliated
More news about: The Inner Circle
Nov 18, 2025, 13:45 ET Alafair Biosciences Announces First Clinical Use of VersaCoat™ Flowable Hydrogel in Foot & Ankle and Hand & Wrist Procedures
gratitude to the surgeons who performed these initial cases and who continue to advance the future of soft-tissue protection," said Sarah Mayes, PhD, Chief Scientific Officer and Co-Founder of Alafair Biosciences. "With VersaCoat as the first syringe-deliverable soft-tissue protector, Alafair
More news about: Alafair Biosciences, Inc.
Nov 18, 2025, 13:09 ET California Black Women's Collective Empowerment Institute Launches the Holly J. Mitchell Girls Empowerment Leadership Institute in partnership with Mount Saint Mary's University
life. "Mount Saint Mary's University is honored to partner with CABWCEI to launch this transformative program," Ann McElaney-Johnson, PhD, President of Mount Saint Mary's University said. "The Holly J. Mitchell Girls Empowerment Leadership Institute embodies our shared belief in
More news about: CA Black Women's Collective Empowerment Institute
Nov 18, 2025, 12:01 ET ISMP Announces 28th Annual Cheers Award Recipients
Society briefing. MiKaela Olsen, DNP, APRN-CNS, AOCNS, FAAN, and AnnMarie Walton, PhD, MPH, RN, OCN, CHES, FAAN Baltimore, MD, and Durham, NC
More news about: Institute for Safe Medication Practices
Nov 18, 2025, 11:00 ET LDF Welcomes New Board Member Dr. Joy Buolamwini
fellow, Dr. Buolamwini holds master's degrees from the University of Oxford and the Massachusetts Institute of Technology, where she also earned her PhD. In 2025, she was selected for the inaugural cohort of the Accelerator Fellowship Programme at the University of Oxford's Institute for Ethics in AI.
More news about: Legal Defense Fund (LDF)
Nov 18, 2025, 10:00 ET Linus Health Highlights AI-Enabled Solutions Advancing Early Alzheimer's Detection and Clinical Trial Readiness at CTAD 2025
traditional patient-reported outcome measures. Authors: Stina Saunders, PhD; Claudio Toro-Serey, PhD; Ali Jannati, MD, PhD; Sean Tobyne, PhD; Craig Ritchie, PhD; Sarah Gregory, PhD; Miles Welstead, PhD; Alvaro Pascual-Leone, MD, PhD P340:
More news about: Linus Health
Nov 18, 2025, 10:00 ET EvE Bio and DrugBank Partner to Bring Record-Scale Pharmome-Mapping Data to the Drug-Discovery Community
"We founded EvE to bring a new field - pharmome mapping - to the aid of the drug discovery and development process," said William Busa, PhD, co-founder and CSO of EvE Bio. "We're quickly onboarding new, fully validated assays and releasing the data multiple times a year at
More news about: EvE Bio
Nov 18, 2025, 09:45 ET A First-of-Its-Kind, Formula-Free Guide to AI and Machine Learning for Decision Makers, by Corina J. Shtir, PhD
world of Artificial Intelligence…"— Scott Taylor, PhD, CEO, Diapeutic; COO, Histologics About the Author Corina J. Shtir, PhD, is a biostatistician and executive specializing in AI applications
More news about: Dexwell Inc.
Nov 18, 2025, 09:00 ET The Galien Foundation Announces 2025 Prix Galien Bridges Awards Nominees for "Best Bridge-Builder Institution," "Best Biomedical Product," "Best Medical Technology/AI Advances in Human Health," "Best Product for Rare/Orphan Diseases," and "Best Public Sector Innovation"
MD, PhDResearch Director of Human Genomics, Institute for Molecular Medicine Finland Erik RENSTRÖM, PhDVice Chancellor, Lund University John-Arne RØTTINGEN, MD, PhDCEO, Wellcome Veronika SEXL, MD, PhDRector,
More news about: The Galien Foundation
Nov 18, 2025, 09:00 ET QUEL Imaging and INO Announce Technology Transfer to Advance Biomedical Optics
measurements using an independent, time-resolved method that's long been regarded as the benchmark for optical property quantification," said Ethan LaRochelle, PhD, CEO and co-founder of QUEL Imaging. "Integrating
More news about: QUEL Imaging
Nov 18, 2025, 09:00 ET AI That Saves Sight: Utah Clinic Uses Breakthrough Technology to Bring Specialty Eye Care Directly to Patients with Diabetes
care through the application of technology in the medical diagnosis and treatment process. The company, originally founded by Michael Abramoff, MD, PhD, a neuroscientist, practicing fellowship-trained retina specialist, and computer engineer, is led by him and co-founder John Bertrand.
More news about: Digital Diagnostics
Nov 18, 2025, 08:46 ET $500,000 Michael F. Price Grant Awarded to MD Anderson for Gastric Cancer Clinical Trial
DeGregorio Family Foundation with support from the Torrey Coast Foundation has awarded a $500,000 Michael F. Price Memorial Grant to Katy Rezvani, MD, PhD, Vice President, Institute for Cell Therapy Discovery & Innovation at The University of Texas MD Anderson Cancer Center.
More news about: DeGregorio Family Foundation
Nov 18, 2025, 08:30 ET Managing Placebo Risk in Dermatology Trials, Upcoming Webinar Hosted by Xtalks
TFS HealthScience, Mesfin James, Head of Regulatory Affairs; Mihály Imre, MD, PhD, Senior Medical Director; and Sonja VanWye, RN, MSN, Project Director, Dermatology, for the live webinar on Tuesday, December 9, 2025, at 11am EST (5pm
More news about: Xtalks
Nov 18, 2025, 08:30 ET Biomarker Testing: Pushing the Limits of Ultrasensitivity, Upcoming Webinar Hosted by Xtalks
KCAS Bio (Lyon), Christine Bain Wendlinger, PhD, Senior Scientific Advisor; and Fabien Lavocat, MSc, Scientist, Bioanalytical Method Development, for the live webinar on Wednesday, December 10, 2025,
More news about: Xtalks
Nov 18, 2025, 08:10 ET SOTERIA and CureMatch Expand Collaboration to Advance Precision Oncology for U.S. Special Operations Forces Battling Cancer
nation." "As a member of the Special Operations community, I've seen the immense toll these cancers take," said Rob Newson, PhD, CAPT, USN, SEAL (Ret.), Chief Community Officer at SOTERIA. "This initiative reflects the best of what's possible when innovation and service come
More news about: SOTERIA Precision Medicine Foundation
Nov 18, 2025, 08:00 ET QuantalX Receives FDA De Novo Clearance for Delphi-MD, Establishing a New Modality of Brain Function Assessment
honored to work with the talented team at QuantalX and use Delphi-MD in our landmark ongoing study, the BrainHealth Project," said Sandra Bond Chapman, PhD, Chief Director of the Center for BrainHealth at University of Texas at Dallas and Co-leader of the BrainHealth Project. "Direct and objective assessment
More news about: QuantalX
Nov 18, 2025, 08:00 ET Triomics implements AI cancer clinical-trial screening to improve access in Connecticut
process, allowing our teams to focus more on enabling patients to enroll to appropriate trials and less on searching through charts," said Ian Krop, MD, PhD, Professor of Medicine (Medical Oncology), and Medical Director, Yale Cancer Center Clinical Trials Office. "By integrating the
More news about: Triomics
Nov 18, 2025, 08:00 ET BlueWhale Bio Receives FDA Advanced Manufacturing Technology (AMT) Designation for Synecta™ Cell-Derived Nanoparticle Platform
future commercial use. "We've seen strong activation performance and high-quality cells with Synecta," said Stephan Kadauke, MD, PhD, Children's Hospital of Philadelphia. "Having an FDA-recognized activation reagent provides valuable assurance as we plan next-generation manufacturing
More news about: BlueWhale Bio, Inc.
Nov 18, 2025, 08:00 ET Vasa Therapeutics Granted FDA Fast Track Designation for VS-041, a Novel Investigational Treatment of Heart Failure with Preserved Ejection Fraction (HFpEF)
pipeline of drug candidates to address unmet medical needs in large groups of patients, capping off a year of strong execution," added Artur Plonowski, MD, PhD, Chief Executive Officer and co-founder of Vasa Therapeutics. "We are currently on track to have two assets in clinical development in 2026. I want
More news about: Vasa Therapeutics
Nov 18, 2025, 08:00 ET Health~Holland Awards Another Innovative Research Grant for DNA Pol IIIC Inhibitors to Leiden University Medical Center and Acurx Pharmaceuticals
inhibitors. Wiep Klaas Smits, PhD, Associate Professor, LUMC Department of Medical Microbiology will be the lead researcher in collaboration with Meindert Lamers, PhD, Associate Professor, LUMC Department of Cell and Chemical Biology and Mia Urem, PhD, from Leiden University Medical Center in
More news about: Acurx Pharmaceuticals, Inc.